IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

India to Remain a Cost-Competitive Hub

10:23 AM MDT | May 22, 2009 | DEEPTI RAMESH

Contract manufacturing of active pharmaceutical ingredients (APIs) and finished dosage drug forms will grow in India at 30%-40%/year until 2013, says a new report from Frost & Sullivan India (F&S; Kolkata). The cost of manufacturing in India is increasing, but the country continues to be a leading destination for outsourcing pharma manufacturing, F&S says. “India has already emerged as one of the most preferred outsourcing hubs for many global players including big pharmaceutical companies, and we can expect more than 30% growth in the contract...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa